If you have type 2 diabetes, your health care provider may recommend Victoza (liraglutide) or Ozempic (semaglutide) to help ...
Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve ...
Lupin has received approval from the Food and Drug Administration for liraglutide injection single-patient-use prefilled pens and glucagon for injection vials. Both of these products will be ...
Hikma recently received the Food and Drug Administration’s permission for a new generic, and the company also launched two new generic products. The FDA approved Hikma's first generic referencing ...
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Liraglutide injection is a GLP-1 receptor agonist used to improve glycemic control in adults and pediatric patients with type 2 diabetes More than 38 million people live with diabetes in the U.S. 1, ...
MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...
If you're looking into weight loss drugs, liraglutide has no doubt popped up. It's a diabetes and weight loss medication sold under the brand names Victoza and Saxenda. Read on for everything you need ...
Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.
Mounjaro is a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with the active ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results